Taken together, these data indicate that the levels of the pro-tumorigenic PGE2 are increased in CRC, which was previously attributed to the increased production via COX-2 up-regulation but more recently has also been attributed to decreased catabolism, reflecting the down-regulation of 15-PGDH. This evidence concerns the gene PTGS2 and colorectal carcinoma.